HuGE Literature Finder
Records
1
-
11
Novel Recurrent Altered Genes in Chinese Patients With Anaplastic Thyroid Cancer. The Journal of clinical endocrinology and metabolism 2021 Jan . Zhang Lingyun, Ren Zhixiang, Su Zhengzheng, Liu Yang, Yang Tian, Cao Minyuan, Jiang Yong, Tang Ying, Chen Haining, Zhang Weihan, Gong Rixiang, Wei Tao, Peng Yong, Liu Bo, Zhang Wei, Yang Li, Hu Yiguo, Li Zhihui, Zhu Jingqiang, Xu Heng, Shu Yang, Luo H |
Effects of the MTOR and AKT1 genes polymorphisms on papillary thyroid cancer development. IUBMB life 2020 Oct . Maruei-Milan Rostam, Saravani Mohsen, Heidari Zahra, Asadi-Tarani Mina, Salimi Saeed |
Genetic profile of advanced thyroid cancers in relation to distant metastasis. Endocrine-related cancer 2020 3 27 (5): 285-293. Song Eyun, Song Dong Eun, Ahn Jonghwa, Kim Tae Yong, Kim Won Bae, Shong Young Kee, Jeon Min Ji, Kim Won |
Global RNA Expression and DNA Methylation Patterns in Primary Anaplastic Thyroid Cancer. Cancers 2020 3 12 (3): . Ravi Naveen, Yang Minjun, Mylona Nektaria, Wennerberg Johan, Paulsson Kaj |
Everolimus in Anaplastic Thyroid Cancer: A Case Series. Frontiers in oncology 2019 3 9 106. Harris Ethan J, Hanna Glenn J, Chau Nicole, Rabinowits Guilherme, Haddad Robert, Margalit Danielle N, Schoenfeld Jonathan, Tishler Roy B, Barletta Justine A, Nehs Matthew, Janne Pasi, Huang Julian, Groden Phillip, Kacew Alec, Lorch Joch |
High Expression of miR-206 Predicts Adverse Outcomes: A Potential Therapeutic Target for Esophageal Cancer. Combinatorial chemistry & high throughput screening 2019 10 22 (9): 599-611. Du Guobo, Zhou Jing, Cheng Long, Ma Xiaojie, Gui Yan, Tan Bangxi |
Detection of Molecular Alterations in Taiwanese Patients with Medullary Thyroid Cancer Using Whole-Exome Sequencing. Endocrine pathology 2018 Aug . Chang Ya-Sian, Chang Chun-Chi, Huang Hsi-Yuan, Lin Chien-Yu, Yeh Kun-Tu, Chang Jan-Gow |
Genomic Correlates of Response to Everolimus in Aggressive Radioiodine-refractory Thyroid Cancer: A Phase II Study. Clinical cancer research : an official journal of the American Association for Cancer Research 2018 1 24 (7): 1546-1553. Hanna Glenn J, Busaidy Naifa L, Chau Nicole G, Wirth Lori J, Barletta Justine A, Calles Antonio, Haddad Robert I, Kraft Stefan, Cabanillas Maria E, Rabinowits Guilherme, O'Neill Anne, Limaye Sewanti A, Alexander Erik K, Moore Francis D, Misiwkeiwicz Krystof, Thomas Tom, Nehs Matthew, Marqusee Ellen, Lee Stephanie L, Jänne Pasi A, Lorch Jochen |
Everolimus in Patients With Advanced Follicular-Derived Thyroid Cancer: Results of a Phase II Clinical Trial. The Journal of clinical endocrinology and metabolism 2016 Nov jc20162525. Schneider T C, de Wit D, Links T P, van Erp N P, van der Hoeven J J M, Gelderblom H, Roozen C F M, Bos M, Corver W E, van Wezel T, Smit J W A, Morreau H, Guchelaar H J, Kapiteijn |
Absence of somatic mutations of the mTOR gene in differentiated thyroid cancer. Meta gene 2015 Dec 6 69-71. Murugan Avaniyapuram Kannan, Humudh Eman A, Qasem Ebtesam, Al-Hindi Hindi, Almohanna Mai, Hassan Zeinab Korany, Alzahrani Ali |
Evaluation of PTEN, PI3K, MTOR, and KRAS expression and their clinical and prognostic relevance to differentiated thyroid carcinoma. Contemporary oncology (Pozna?, Poland) 2014 18 (4): 234-40. Duman Berna B, Kara O?uz I, U?uz Aysum, Ates Berna |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 22, 2023
- Content source: